Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 AB INBEV ABI May 17, 2021 61.95 -0.59   
 Ackermans & van Haaren NV ACKB May 17, 2021 135.30 -0.66   
 Aedifica SA AED May 17, 2021 102.60 +0.49   
 Ageas AGS May 17, 2021 52.60 -0.42   
 APERAM APAM May 17, 2021 46.58 +1.24   
 Argen X SE ARGX May 17, 2021 226.20 +2.40   
 Barco NV BAR May 17, 2021 20.52 +0.59   
 Bel20 BEL20 May 17, 2021 4 072.15 +0.14   
 Cofinimmo COFB May 17, 2021 126.20 -3.74   
 Colruyt SA COLR May 17, 2021 50.96 +1.07   
 GALAPAGOS GLPG May 17, 2021 63.34 +0.46   
 Groupe Bruxelles Lambert SA GBLB May 17, 2021 90.74 +0.02   
 ING GROEP N.V. INGA May 17, 2021 10.92 +0.57   
 KBC Groep NV KBC May 17, 2021 68.20 -0.38   
 Proximus SADP PROX May 17, 2021 17.23 +1.47   
 Sofina SA SOF May 17, 2021 313.00 +0.26   
 Solvay SA SOLB May 17, 2021 111.70 -1.28   
 Telenet Group Holding NV TNET May 17, 2021 33.90 +1.13   
 UCB SA UCB May 17, 2021 79.30 +1.90   
 Umicore SA UMI May 17, 2021 49.99 0.00   
 Warehousing & Distribution De Pauw WDP May 17, 2021 29.84 +0.88   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK